174 related articles for article (PubMed ID: 19442139)
1. Irreversible inhibition of serine proteases - design and in vivo activity of diaryl alpha-aminophosphonate derivatives.
Sieńczyk M; Oleksyszyn J
Curr Med Chem; 2009; 16(13):1673-87. PubMed ID: 19442139
[TBL] [Abstract][Full Text] [Related]
2. Phosphonic esters and their application of protease control.
Grzywa R; Sieńczyk M
Curr Pharm Des; 2013; 19(6):1154-78. PubMed ID: 23016683
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
Jankun J; Skrzypczak-Jankun E
Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
[TBL] [Abstract][Full Text] [Related]
4. Proteinase 3 phosphonic inhibitors.
Grzywa R; Lesner A; Korkmaz B; Sieńczyk M
Biochimie; 2019 Nov; 166():142-149. PubMed ID: 30876969
[TBL] [Abstract][Full Text] [Related]
5. Coumarin and isocoumarin as serine protease inhibitors.
Pochet L; Frédérick R; Masereel B
Curr Pharm Des; 2004; 10(30):3781-96. PubMed ID: 15579071
[TBL] [Abstract][Full Text] [Related]
6. Development and binding characteristics of phosphonate inhibitors of SplA protease from Staphylococcus aureus.
Burchacka E; Zdzalik M; Niemczyk JS; Pustelny K; Popowicz G; Wladyka B; Dubin A; Potempa J; Sienczyk M; Dubin G; Oleksyszyn J
Protein Sci; 2014 Feb; 23(2):179-89. PubMed ID: 24375505
[TBL] [Abstract][Full Text] [Related]
7. In-cell selectivity profiling of serine protease inhibitors by activity-based proteomics.
Gillet LC; Namoto K; Ruchti A; Hoving S; Boesch D; Inverardi B; Mueller D; Coulot M; Schindler P; Schweigler P; Bernardi A; Gil-Parrado S
Mol Cell Proteomics; 2008 Jul; 7(7):1241-53. PubMed ID: 18364346
[TBL] [Abstract][Full Text] [Related]
8. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
9. A Bisbenzamidine Phosphonate as a Janus-faced Inhibitor for Trypsin-like Serine Proteases.
Häußler D; Scheidt T; Stirnberg M; Steinmetzer T; Gütschow M
ChemMedChem; 2015 Oct; 10(10):1641-6. PubMed ID: 26306030
[TBL] [Abstract][Full Text] [Related]
10. Peptidic phosphonylating agents as irreversible inhibitors of serine proteases and models of the tetrahedral intermediates.
Sampson NS; Bartlett PA
Biochemistry; 1991 Feb; 30(8):2255-63. PubMed ID: 1998684
[TBL] [Abstract][Full Text] [Related]
11. Phosphonic pseudopeptides as human neutrophil elastase inhibitors--a combinatorial approach.
Sieńczyk M; Podgórski D; Błażejewska A; Kulbacka J; Saczko J; Oleksyszyn J
Bioorg Med Chem; 2011 Feb; 19(3):1277-84. PubMed ID: 21216608
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in the design of mechanism-based and alternate substrate inhibitors of serine proteases.
Zhong J; Groutas WC
Curr Top Med Chem; 2004; 4(12):1203-16. PubMed ID: 15320721
[TBL] [Abstract][Full Text] [Related]
13. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
Wang Q; Shaltiel S
BMC Biochem; 2003 Jul; 4():5. PubMed ID: 12848892
[TBL] [Abstract][Full Text] [Related]
14. Ligand-Based Design of Selective Peptidomimetic uPA and TMPRSS2 Inhibitors with Arg Bioisosteres.
Müller P; Zimmer C; Frey A; Holzmann G; Weldert AC; Schirmeister T
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338655
[TBL] [Abstract][Full Text] [Related]
15. α-Amino-α'-halomethylketones: synthetic methodologies and pharmaceutical applications as serine and cysteine protease inhibitors.
Pace V; Castoldi L; Pregnolato M
Mini Rev Med Chem; 2013 Jun; 13(7):988-96. PubMed ID: 22931530
[TBL] [Abstract][Full Text] [Related]
16. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and kinetic studies of diphenyl 1-(N-peptidylamino)alkanephosphonate esters and their biotinylated derivatives as inhibitors of serine proteases and probes for lymphocyte granzymes.
Abuelyaman AS; Jackson DS; Hudig D; Woodard SL; Powers JC
Arch Biochem Biophys; 1997 Aug; 344(2):271-80. PubMed ID: 9264539
[TBL] [Abstract][Full Text] [Related]
18. Alpha-ketoamides, alpha-ketoesters and alpha-diketones as HCV NS3 protease inhibitors.
Han W; Hu Z; Jiang X; Decicco CP
Bioorg Med Chem Lett; 2000 Apr; 10(8):711-3. PubMed ID: 10782670
[TBL] [Abstract][Full Text] [Related]
19. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters.
Oleksyszyn J; Powers JC
Biochemistry; 1991 Jan; 30(2):485-93. PubMed ID: 1988040
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of the protease domain of urokinase-type plasminogen activator.
Rockway TW; Nienaber V; Giranda VL
Curr Pharm Des; 2002; 8(28):2541-58. PubMed ID: 12369939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
